Immune responses to a Staphylococcus aureus GapC/B chimera and its potential use as a component of a vaccine for S. aureus mastitis

Veterinary Immunology and Immunopathology

Volumn 109, Issue 1-2, 2006, Pages 85-97

  Perez Casal, Jose ^a   Prysliak, Tracy ^a   Kerro Dego, Oudessa ^a   Potter, Andrew A ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Mastitis; Protein chimeras; S. aureus; Vaccines

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; INTERLEUKIN 4; PROTEIN; PROTEIN GAPB; PROTEIN GAPC; STAPHYLOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL SECRETION; CELLULAR IMMUNITY; CHIMERA; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG RESPONSE; HUMORAL IMMUNITY; IMMUNE RESPONSE; MASTITIS; MOUSE; NONHUMAN; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTIBODIES, BACTERIAL; CATTLE; DNA, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; IMMUNIZATION; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-4; MASTITIS, BOVINE; MICE; MICE, INBRED C57BL; RECOMBINANT FUSION PROTEINS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL VACCINES; STAPHYLOCOCCUS AUREUS;

ANIMALIA; BOVINAE; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 28444431640     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2005.07.024     Document Type: Article

References (29)

1. L.L. Argiro, S.S. Kohlstadt, S.S. Henri, H.H. Dessein, V.V. Matabiau, P.P. Paris, A.A. Bourgois, and A.J. Dessein Identification of a candidate vaccine peptide on the 37 kDa Schistosoma mansoni GAPDH Vaccine 18 2000 2039 2048
2. A. Bolton, X.M. Song, P. Willson, M.C. Fontaine, A.A. Potter, and J. Perez-Casal Use of the surface proteins GapC and Mig of Streptococcus dysgalactiae as potential protective antigens against bovine mastitis Can. J. Microbiol. 50 2004 423 432
3. E. Brouillette, P. Lacasse, L. Shkreta, J. Belanger, G. Grondin, M.S. Diarra, S. Fournier, and B.G. Talbot DNA immunization against the clumping factor A (ClfA) of Staphylococcus aureus Vaccine 20 2002 2348 2357
4. F.J. DeGraves, and J. Fetrow Economics of mastitis and mastitis control Vet. Clin. North Am. Food Anim. Pract. 9 1993 421 434
5. M.L. Delgado, J.E. O'Connor, I. Azorin, J. Renau-Piqueras, M.L. Gil, and D. Gozalbo The glyceraldehyde-3-phosphate dehydrogenase polypeptides encoded by the Saccharomyces cerevisiae TDH1, TDH2 and TDH3 genes are also cell wall proteins Microbiology 147 2001 411 417
6. M.C. Fontaine, J. Perez-Casal, X.M. Song, J. Shelford, P.J. Willson, and A.A. Potter Immunisation of dairy cattle with recombinant Streptococcus uberis GapC or a chimeric CAMP antigen confers protection against heterologous bacterial challenge Vaccine 20 2002 2278 2286
7. I. Gil-Navarro, M.L. Gil, M. Casanova, J.E. O'Connor, J.P. Martinez, and D. Gozalbo The glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase of Candida albicans is a surface antigen J. Bacteriol. 179 1997 4992 4999
8. N. Goji, A.A. Potter, and J. Perez-Casal Characterization of two proteins of Staphylococcus aureus isolated from clinical mastitis with homology to glyceraldehyde-3-phosphate dehydrogenase Vet. Microbiol. 99 2004 269 279
9. S. Gottesman, E. Halpern, and P. Trisler Role of sulA and sulB in filamentation by lon mutants of Escherichia coli K-12 J. Bacteriol. 148 1981 265 273
10. D. Gozalbo, I. Gil-Navarro, I. Azorin, J. Renau-Piqueras, J.P. Martinez, and M.L. Gil The cell wall-associated glyceraldehyde-3-phosphate dehydrogenase of Candida albicans is also a fibronectin and laminin binding protein Infect. Immun. 66 1998 2052 2059
11. M. Hoedemaker, B. Korff, B. Edler, M. Emmert, and E. Bleckmann Dynamics of Staphylococcus aureus infections during vaccination with an autogenous bacterin in dairy cattle J. Vet. Med. B Infect. Dis. Vet. Public Health 48 2001 373 383
12. C.Y. Hwang, S.I. Pak, and H.R. Han Effects of autogenous toxoid-bacterin in lactating cows with Staphylococcus aureus subclinical mastitis J. Vet. Med. Sci. 62 2000 875 880
13. X.P. Ioannou, S.M. Gomis, B. Karvonen, R. Hecker, L.A. Babiuk, and S. van Drunen Littel-van den Hurk CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein Vaccine 21 2002 127 137
14. G. Leitner, E. Lubashevsky, A. Glickman, M. Winkler, A. Saran, and Z. Trainin Development of a Staphylococcus aureus vaccine against mastitis in dairy cows. I. Challenge trials Vet. Immunol. Immunopathol. 93 2003 31 38
15. G. Leitner, N. Yadlin, E. Lubashevsky, E. Ezra, A. Glickman, M. Chaffer, M. Winkler, A. Saran, and Z. Trainin Development of a Staphylococcus aureus vaccine against mastitis in dairy cows. II. Field trial Vet. Immunol. Immunopathol. 93 2003 153 158
16. B. Modun, and P. Williams The staphylococcal transferrin-binding protein is a cell wall glyceraldehyde-3-phosphate dehydrogenase Infect. Immun. 67 1999 1086 1092
17. V. Muller-Schollenberger, W. Beyer, P. Schinitzler, A. Merckerbach, S.H.K.B. Roth, and R. Lucius Immunization with Salmonella typhimurium-delivered glyceraldehyde-3-phosphate dehydrogenase protects mice against challenge infection with Echinococcus multilocularis eggs Intl. J. Parasitol. 31 2001 1441 1449
18. W.E. Owen, C.H. Ray, R.L. Boddie, and S.C. Nickerson Efficacy of sequential intrammamary antibiotic treatment against chronic Staphylococcus aureus intramammary infection Large Anim. Practise 18 1985 10 14
19. V. Pancholi, and V.A. Fischetti A major surface protein on group A streptococci is a glyceraldehyde-3- phosphate-dehydrogenase with multiple binding activity J. Exp. Med. 176 1992 415 426
20. V. Pancholi, and V.A. Fischetti Glyceraldehyde-3-phosphate dehydrogenase on the surface of group A streptococci is also an ADP-ribosylating enzyme Proc. Natl. Acad. Sci. U.S.A. 90 1993 8154 8158
21. J. Perez-Casal, T. Prysliak, and A.A. Potter A GapC chimera retains the properties of the Streptococcus uberis wild-type GapC protein Protein Expr. Purif. 33 2004 288 296
22. G.M. Rosinha, A. Myioshi, V. Azevedo, G.A. Splitter, and S.C. Oliveira Molecular and immunological characterisation of recombinant Brucella abortus glyceraldehyde-3-phosphate-dehydrogenase, a T- and B-cell reactive protein that induces partial protection when co-administered with an interleukin-12- expressing plasmid in a DNA vaccine formulation J. Med. Microbiol. 51 2002 661 671
23. Sears, P., 2002. Staphylococcal Vaccines: What are the New Strategies. National Mastitis Council Annual Meeting, Orlando, Fl. 73-79.
24. L. Shkreta, B.G. Talbot, M.S. Diarra, and P. Lacasse Immune responses to a DNA/protein vaccination strategy against Staphylococcus aureus induced mastitis in dairy cows Vaccine 23 2004 114 126
25. M.A. Sirover New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase Biochim. Biophys. Acta. 1432 1999 159 184
26. J.M. Taylor, and D.E. Heinrichs Transferrin binding in Staphylococcus aureus: involvement of a cell wall-anchored protein Mol. Microbiol. 43 2002 1603 1614
27. B.A. Tenhagen, D. Edinger, B. Baumgartner, P. Kalbe, G. Klunder, and W. Heuwieser Efficacy of a herd-specific vaccine against Staphylococcus aureus to prevent post-partum mastitis in dairy heifers J. Vet. Med. A Physiol. Pathol. Clin. Med. 48 2001 601 607
28. Timms, L., 2001. Evaluation of recommended and extended pirlimycin therapy strategies in four high somatic cell count herds. In: Proceedings Second International Mastitis Milk Quality Symposium, 534-535.
29. W.Q. Zang, A.M. Fieno, R.A. Grant, and T.S. Yen Identification of glyceraldehyde-3-phosphate dehydrogenase as a cellular protein that binds to the hepatitis B virus posttranscriptional regulatory element Virology 248 1998 46 52